Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Tribble

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Experimental Eye Research|June 28, 2015
Microbead models in glaucomaJames E Morgan, James R Tribble
Neural Regeneration Research|December 30, 2025
Treating dysfunctional one-carbon metabolism in glaucomaJames R Tribble, Pete A Williams
Journal of Clinical Medicine|September 10, 2021
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell NeuroprotectionTim J Enz, James R Tribble, Pete A Williams
Frontiers in Ophthalmology|July 10, 2024
Glial metabolic alterations during glaucoma pathogenesisAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Molecular Brain|November 22, 2024
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucomaAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Brain Research Bulletin|June 22, 2025
Amino acid neurotransmitters in sarcopenia and healthy agingSteffi M Jonk, James R Tribble, Peter Swoboda, et al.
Acta Neuropathologica Communications|March 1, 2024
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volumeAmin Otmani, Gauti Jóhannesson, Rune Brautaset, et al.
Molecular Brain|November 23, 2018
Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucomaJames R Tribble, Pete A Williams, Bruce Caterson, et al.
Acta Neuropathologica Communications|August 23, 2024
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucomaGloria Cimaglia, James R Tribble, Marcela Votruba, et al.
Molecular Brain|May 27, 2020
Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J miceJames R Tribble, Jeffrey M Harder, Pete A Williams, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Experimental Eye Research|June 28, 2015
Microbead models in glaucomaJames E Morgan, James R Tribble
Neural Regeneration Research|December 30, 2025
Treating dysfunctional one-carbon metabolism in glaucomaJames R Tribble, Pete A Williams
Journal of Clinical Medicine|September 10, 2021
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell NeuroprotectionTim J Enz, James R Tribble, Pete A Williams
Frontiers in Ophthalmology|July 10, 2024
Glial metabolic alterations during glaucoma pathogenesisAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Molecular Brain|November 22, 2024
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucomaAnne Rombaut, Rune Brautaset, Pete A Williams, et al.
Brain Research Bulletin|June 22, 2025
Amino acid neurotransmitters in sarcopenia and healthy agingSteffi M Jonk, James R Tribble, Peter Swoboda, et al.
Acta Neuropathologica Communications|March 1, 2024
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volumeAmin Otmani, Gauti Jóhannesson, Rune Brautaset, et al.
Molecular Brain|November 23, 2018
Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucomaJames R Tribble, Pete A Williams, Bruce Caterson, et al.
Acta Neuropathologica Communications|August 23, 2024
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucomaGloria Cimaglia, James R Tribble, Marcela Votruba, et al.
Molecular Brain|May 27, 2020
Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J miceJames R Tribble, Jeffrey M Harder, Pete A Williams, et al.
Pageof 5